Fangzhou Inc (HKSE:06086) Share Price

Company Profile

Business description
Fangzhou Inc is a online chronic disease management platform in China. It has focus on chronic disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. The company provide comprehensive medical services and online retail pharmacy services through Jianke Platform. The principal segment of the group are online retail pharmacy services, comprehensive medical services, Wholesale and customized content and marketing solutions. Key revenue is generated from Online retail pharmacy services.
Contact
4th Street
Floor 1-2, Building S, Kehui Jingu
No. 99, Science Avenue, Luogang Science City
Huangpu District, Guangdong Province
Guangzhou
CHN
https://investors.jianke.com
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2025
Employees
488

Recommended

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Malik Ahmed Khan, CFA | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,994.70	20.70	-0.23%
CAC 40	7,861.96	4.60	0.06%
DAX 40	24,262.22	44.85	0.19%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,136.94	0.62	0.01%
HKSE	24,879.66	297.27	-1.18%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	40,960.45	305.75	0.75%
NZX 50 Index	12,830.37	25.60	-0.20%
S&P 500	6,362.90	7.96	-0.12%
S&P/ASX 200	8,738.30	18.10	-0.21%
SSE Composite Index	3,591.26	24.46	-0.68%